JPRN-jRCT1090220372CompletedUnknown
Continuous glucose monitoring (CGM) in advanced neurodegenerative diseases - CGM in neurodegenerative diseases
ational Health Organization Hyogo-Chuo National Hospital0 sites10 target enrollmentStarted: August 3, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •Bedridden neurodegenerative diseases under enteral feeding
Exclusion Criteria
- •Severe systemic diseases, use of mechanical ventilation
Investigators
Similar Trials
Recruiting
Not Applicable
Continuous Glucose Monitoring (CGM) for women with Gestational Diabetes Mellitus (GDM) study: pilotGestational diabetesMetabolic and Endocrine - DiabetesReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12618000050257Mercy Health (Werribee Mercy Hospital)100
Recruiting
Unknown
CGM-HYPE: Continuous glucose monitoring in healthy young people under standardized conditionsE11Type 2 diabetes mellitusDRKS00032821Heinrich-Heine Universität Düsseldorf10
Completed
Not Applicable
Continuous Glucose Monitoring(CGM) in Acute Ischemic StrokeAcute StrokeJPRN-UMIN000005638Department of Stroke Medicine, Kawasaki Medical School100
Recruiting
Unknown
Diagnostic continuous glucose monitoring to improve the care of pediatric patients with hypocortisolismDRKS00033148niversitätsklinikum Düsseldorf20
Completed
Not Applicable
Monitoring of plasma glucose using continuous glucose measurement system (CGMs) in patients with peritoneal dialysisperitoneal dialysis patientsJPRN-UMIN000014916Department of Nephrology, Fujita Health University School of Medicine50